Literature DB >> 19217650

Is remitting seronegative symmetrical synovitis with pitting edema (RS3PE) a subset of rheumatoid arthritis?

Qingping Yao1, Xiangqian Su, Roy D Altman.   

Abstract

OBJECTIVES: To contrast and compare the spectrum of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) with rheumatoid arthritis (RA) using an illustrative case.
METHODS: The relevant English literature of RS3PE was searched using the keywords "RS3PE" alone and in combination with terms such as neoplasia and rheumatic disease. Original and review articles were reviewed and the clinical setting was exemplified with a case report.
RESULTS: RS3PE initially was reported to represent a form of RA. However, RS3PE has clinical features that are different from both early- and late-onset RA, such as lack of bony erosions and rheumatoid factor. RS3PE is thought to involve vascular endothelial growth factor, suggesting an infectious etiology, generally has an excellent prognosis, and is associated with neoplasia not commonly seen in RA, and the RA associated human leukocyte antigen (HLA) DRB1 genotype is absent.
CONCLUSIONS: Based on the clinical, laboratory, suspected infectious etiology, genetic differences, and types of associated malignancies, RS3PE appears to be a distinct entity rather than a subset of RA. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217650     DOI: 10.1016/j.semarthrit.2008.11.006

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  15 in total

1.  Lucky to meet RS3PE.

Authors:  Cláudia Ferrao; Raquel M Faria; Pedro Farrajota; Carlos Vasconcelos
Journal:  BMJ Case Rep       Date:  2013-10-07

Review 2.  Paraneoplastic syndromes in rheumatology.

Authors:  Bernhard Manger; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 3.  RS3PE: Clinical and Research Development.

Authors:  Hongbin Li; Roy D Altman; Qingping Yao
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

4.  Remitting seronegative symmetrical synovitis with pitting edema following acute intracranial hemorrhage.

Authors:  Deng-Ho Yang; Deh-Ming Chang; Jenn-Haung Lai; Guo-Shu Huang; Wei-Chou Chang; Tsung-Yun Hou
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

5.  Complications of intravesical bacillus calmette-guérin.

Authors:  Liam C Macleod; Tin C Ngo; Mark L Gonzalgo
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 6.  [Paraneoplastic syndromes in rheumatology].

Authors:  J Leipe; H Schulze-Koops
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

7.  Remitting seronegative symmetrical synovitis with pitting edema syndrome in a chronic hemodialysis patient.

Authors:  Shunsuke Yamada; Seiya Fuyuno; Masahiro Eriguchi; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Case Rep Med       Date:  2012-01-29

8.  Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.

Authors:  Shozaburo Yanamoto; Jiro Fukae; Yurie Fukiyama; Shinsuke Fujioka; Shinji Ouma; Yoshio Tsuboi
Journal:  J Med Case Rep       Date:  2016-07-20

9.  Syndrome of remitting seronegative symmetrical synovitis with pitting edema: a case series.

Authors:  A N Varshney; N K Singh
Journal:  J Postgrad Med       Date:  2015 Jan-Mar       Impact factor: 1.476

10.  Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy.

Authors:  Naba Raj Mainali; Torrey R Schmidt; Richard Alweis; David L George
Journal:  Am J Case Rep       Date:  2014-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.